THE IMPACT OF FREMANEZUMAB ON MIGRAINE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN CHRONIC MIGRAINE PATIENTS WITH CONCOMITANT PREVENTIVE MEDICATION USE

被引：0
|
作者：
Lipton, R. B. [1 ,2 ]
Fitzgerald, T. [3 ]
Cohen, J. M. [3 ]
Gandhi, S. K. [3 ]
机构：
[1] Albert Einstein Coll Med, New York, NY USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[3] Teva Pharmaceut, Frazer, PA USA
来源：
CEPHALALGIA | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [41] Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine
    Seo, Jong-Geun
    Park, Sung-Pa
    JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE, 2017, 31 (03) : 251 - 256
  • [42] Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
    Bagley, Christine L.
    Rendas-Baum, Regina
    Maglinte, Gregory A.
    Yang, Min
    Varon, Sepideh F.
    Lee, Jeff
    Kosinski, Mark
    HEADACHE, 2012, 52 (03): : 409 - 421
  • [43] The impact of fremanezumab on symptoms associated with migraine in patients with chronic migraine
    McAllister, Peter
    Yeung, Paul P.
    Aycardi, Ernesto
    Yang, Ronghua
    Ma, Yuju
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [44] IMPROVEMENTS IN MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE (MSQ) DOMAIN SCORES WITH FREMANEZUMAB AND GALCANEZUMAB IN PATIENTS WITH MULTIPLE PRIOR MIGRAINE PREVENTIVE TREATMENT FAILURES: A NETWORK META-ANALYSIS
    Mu, F.
    Driessen, M. T.
    Cohen, J. M.
    Wang, Y.
    Ayyagari, R.
    VALUE IN HEALTH, 2021, 24 : S158 - S158
  • [45] The Impact of Fremanezumab on Symptoms Associated with Migraine in Patients with Chronic Migraine
    McAllister, P.
    Yeung, P. P.
    Aycardi, E.
    Yang, R.
    Ma, Y.
    Cohen, J. M.
    HEADACHE, 2018, 58 : 87 - 87
  • [46] Monthly Migraine Days, Acute Medication Use Days, and Migraine-Specific Quality of Life in Responders to Atogepant: A Post Hoc Analysis
    Dodick, D.
    Lipton, R.
    Nahas, S.
    Pozo-Rosich, P.
    McAllister, P.
    Mechtler, L.
    Ma, J.
    Dabruzzo, B.
    Dufek, M.
    Severt, L.
    Finnegan, M.
    Trugman, J.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1)
  • [47] Impact of fremanezumab on migraine-specific quality of life in patients with medication overuse and documented inadequate response to 2-4 classes of migraine preventive treatments: subgroup analysis of the international, multicentre, randomised, double-blind FOCUS study
    Mechtler, Laszlo
    Ramirez-Campos, Verena
    Cohen, Joshua M.
    Janka, Lindsay
    CEPHALALGIA, 2019, 39 : 221 - 221
  • [48] Monthly migraine days, acute medication use days, and migraine-specific quality of life in responders to atogepant: A post hoc analysis
    Dodick, D. W.
    Lipton, R. B.
    Nahas, S. J.
    Pozo-Rosich, P.
    McAllister, P.
    Mechtler, L. L.
    Ma, J.
    Dabruzzo, B. L.
    Dufek, M.
    Severt, L.
    Finnegan, M.
    Trugman, J. M.
    HEADACHE, 2022, 62 : 152 - 153
  • [49] Impact of Migraine on the Tinnitus-Specific Health-Related Quality of Life and Psychiatric Comorbidities in Patients with Tinnitus
    Kabaya, Kayoko
    Takahashi, Mariko
    Esaki, Shinichi
    Minakata, Toshiya
    Iwasaki, Shinichi
    OTOLOGY & NEUROTOLOGY, 2024, 45 (08) : e570 - e575
  • [50] Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse
    Alberto Raggi
    Ambra Mara Giovannetti
    Silvia Schiavolin
    Matilde Leonardi
    Gennaro Bussone
    Licia Grazzi
    Susanna Usai
    Marcella Curone
    Paola Di Fiore
    Domenico D’Amico
    Quality of Life Research, 2014, 23 : 1273 - 1277
12345